Inventiva Pharma
Martine Zimmermann has been the Senior Vice President and Head of global regulatory affairs of Alexion Pharma International since June 2016. During her 25 years of experience in the pharmaceutical industry, she has acquired extensive expertise in regulatory affairs in both small and large pharmaceutical groups, holding senior roles in the United States, Europe and Asia-Pacific. Martine Zimmermann has worked across all phases of drug development within several therapeutic areas, interacting with relevant regulatory authorities in key markets, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
She is also an active member of several life-sciences trade associations and has been a member of the Board of Directors of U.S.-based Caelum Biosciences since 2019.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Inventiva Pharma
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology.